ⓔPharma Pulse
Volume - 4 | Issue - 197 | 10th - 15th August 2021
|
|
|
PM, Shri Narendra Modi addressed the nation on the 75th Independence Day
Announced 100 lakh crores National Master Plan of Prime Minister ‘Gati Shakti’
|
|
|
Prime Minister Shri Narendra Modi addressed the nation from the Red Fort as the country celebrated its 75th Independence Day.
During the speech, PM Modi listed the achievements of his government and laid out plans for the future. He made an addition to his popular slogan of “Sabka Saath, Sabka Vikas and Sabka Vishwas.” The latest entrant to this group is “Sabka Prayas.”. Read More
|
|
|
First Nasal Vaccine Developed by Bharat Biotech supported by DBT-BIRAC gets nod of regulator for Phase 2 Trial
|
|
|
The Department of Biotechnology (DBT) and its PSU, Biotechnology Industry Research Assistance Council (BIRAC) have been at the forefront in the fight against the prevailing global crisis.
They together have strategized to fast-track R & D efforts especially for vaccine development, diagnostics, drug repurposing, therapeutics and testing. The development of vaccines has been the top priority of the Department of Biotechnology. Read More
|
|
|
DCGI Approves Study On COVAXIN And Covishield Mixing After ICMR Study Report
|
|
|
India's drug regulator has given approval for a study to be conducted by the Christian Medical College (CMC), Vellore on mixing of COVID-19 vaccines Covaxin and Covishield, official sources said on Wednesday. An expert panel of the Central Drugs Standard Control Organisation (CDSCO) on July 29 had recommended granting permission for conducting the study.
The trial will involve 300 healthy volunteers. "The aim of the study is to assess the feasibility on whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- to complete the inoculation course," Read More
|
|
|
Ministry of Health and Ayush will work in synergy to integrate Ayush in the healthcare delivery system of the country
|
|
|
A high-powered meeting of ministers, secretaries and other senior officials of the Ministry of Ayush and Ministry of Health and Family Welfare was organised today at Nirman Bhawan to strengthen the process of integration of Ayush system in public health.
Under the stewardship of both cabinet Ministers, Shri Mansukh L Mandaviya (MoHFW) and Shri Sarbanand Sonowal (MoAyush) both Ministries committed to streamline and operationalise a comprehensive approach of integration in the field of healthcare delivery system in the country as expected by Primie Minister shri Narendra Modi. Read More
|
|
|
Global S&T Research and Initiative
|
|
|
The Ministry of Science and Technology has key partnerships in the emerging areas of Science and Technology. All Departments under the Ministry has dedicated Programme Divisions supporting Innovations, Research Development and Demonstration (R, D & D) Projects and Capacity Building in the flagged areas. India is a partner in many multilateral initiatives addressing global challenges such as clean energy through Mission Innovation, Anti Microbial Resistance through Global AMR Research and Development (R&D) Hub, Grand Challenges India and others.
The Mission Innovation (MI) is a global initiative of 22 countries and the European Commission (on behalf of the European Union) catalyzing investment in research, development and demonstration to make clean energy affordable, attractive and accessible for all. Read More
|
|
|
NPPA has put a cap on Trade Margin of 42 select non-scheduled anti-cancer medicines under ‘Trade Margin Rationalization
|
|
|
NPPA has put a cap on Trade Margin of 42 select non-scheduled anti-cancer medicines under ‘Trade Margin Rationalization (TMR)’ Approach resulting in a reduction up to 90% of Maximum Retail Price (MRP) of 526 brands of these medicines. The total annual savings on account of revision of ceiling prices of medicines are estimated to the tune of Rs. 12,500 crore.
NPPA monitors the ceiling price of the scheduled formulations to ensure that the MRP of such formulations are within the range of ceiling price and monitors non-scheduled formulations to ensure that their MRP does not increase by more than 10% during the preceding twelve months. Read More
|
|
|
Chief Scientist, WHO Dr Soumya Swaminathan, currently in India, calls on Union Minister Dr Jitendra Singh and discusses various aspects of COVID pandemic
|
|
|
Chief Scientist WHO Dr Soumya Swaminathan, currently in India, today called on Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh.
Dr Soumya, who is an eminent medical professional and former Head of ICMR, discussed with Dr Jitendra Singh various aspects of the current COVID pandemic as well as a wide range of other issues. Read More
|
|
|
India achieves 100 GW Milestone of Installed Renewable Energy Capacity
4th position in the world in terms of installed RE capacity, 5th in solar and 4th in wind in terms of installed capacity
|
|
|
The total installed renewable energy capacity in India, excluding large hydro, has crossed the mile-stone of 100 GW.Today India stands at 4th position in the world in terms of installed RE capacity, 5th in solar and 4th in wind in terms of installed capacity.
India has set ambitious targets for itself in the area of Renewable Energy, which the Ministry of New and Renewable Energy is committed to achieve. Read More
|
|
|
PM addresses Investor Summit in Gujarat
|
|
|
Prime Minister Shri Narendra Modi addressed the Investor Summit in Gujarat via video conference. The Summit is being organized to invite investment for setting up vehicle scrapping infrastructure under the Voluntary Vehicle-Fleet Modernization Program or the Vehicle Scrapping Policy.
It will also draw focus on the synergies presented by the ship breaking industry at Alang, for development of an integrated scrapping hub. Union Minister for Road Transport & Highways and Chief Minister of Gujarat were also present on the occasion. Read More
|
|
|
USFDA Officials visited FDCA Gujarat to attend their Regulatory Forum meet for sharing of work done during COVID-19
|
|
|
US FDA's new Country Director (India) - Dr. Sarah McMullen, Christopher Priddy, JD – International Relations Specialist, Sudheendra Kulkarni (Medical Product Safety Coordinator), US FDA India, Dhruv Shah, Medical Product Safety Coordinator, US FDA visited The Gujarat Food and Drug Control Administration (FDCA) to attend regulatory forum meeting for information sharing and capacity building to tackle Covid-19 pandemic.
“This was Dr. Sarah's first visit to Gujarat after she was appointed as Country director, USFDA India office. She is the fifth Country director of India to visit Gujarat FDCA. The first was Bruce Ross who visited in the year 2010. Bruce Ross manages oversees foreign offices of FDA,” stated Gujarat FDCA Commissioner Dr. H G Koshia. Read More
|
|
|
Brain Storming Session on DPSRU-NIB Certificate Program on Quality Control of Biopharmaceuticals
|
|
|
National Institute of Biologicals (NIB), an apex autonomous Institute under Ministry of Health & Family Welfare and Delhi Pharmaceutical Sciences and Research University (DPSRU), Govt of NCT of Delhi, the first Pharmacy University in India joined hands to initiate a certificate Program on Quality Control of BioPharmaceuticals.
The Scientific team headed by Dr. Anup Anvikar, Director NIB, visited DPSRU on Friday 13th August 2021. The meeting was chaired by Prof. Ramesh K Goyal Vice Chancellor DPSRU and Dr. Anup Anvikar, Director NIB. Read More
|
|
|
BoA of the Accuprec, speaker at L. M. College of Pharmacy
|
|
|
On 13th August 2021, Tolani Commerce College and L. M. College of Pharmacy organized and DST-GUJCOST sponsored a webinar on "Intellectual Property Rights and Patenting".
Our Respected Mr. Padmin Buch (Advisor-Corporate Strategy & IPR, Ex-MD - GITCO, BoA of Accuprec) was the Guest of Honour at the event. He delivered the keynote address at the event.
|
|
|
Accuprec has successfully received the extension of approval of Accreditations midst COVID19
|
|
|
In the midst of the COVID19, Accuprec has been successfully faced and received the extension of approval for GLP and ISO certification to provide the ACCURATE & PRECISE results to our clients.
|
|
|
|
|